FI72724C - Foerfarande foer framstaellning av terapeutiskt aktiv, vattenloeslig associationsprodukt av (+)-katekin. - Google Patents
Foerfarande foer framstaellning av terapeutiskt aktiv, vattenloeslig associationsprodukt av (+)-katekin. Download PDFInfo
- Publication number
- FI72724C FI72724C FI802652A FI802652A FI72724C FI 72724 C FI72724 C FI 72724C FI 802652 A FI802652 A FI 802652A FI 802652 A FI802652 A FI 802652A FI 72724 C FI72724 C FI 72724C
- Authority
- FI
- Finland
- Prior art keywords
- catechin
- acid
- solution
- lysine
- added
- Prior art date
Links
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 43
- 229930013915 (+)-catechin Natural products 0.000 description 36
- 235000007219 (+)-catechin Nutrition 0.000 description 36
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 31
- 239000000243 solution Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000004472 Lysine Substances 0.000 description 16
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 15
- 235000019766 L-Lysine Nutrition 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 10
- 229930064664 L-arginine Natural products 0.000 description 10
- 235000014852 L-arginine Nutrition 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 239000011668 ascorbic acid Substances 0.000 description 9
- 229960005070 ascorbic acid Drugs 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 229960000443 hydrochloric acid Drugs 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000019445 benzyl alcohol Nutrition 0.000 description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- 229950001002 cianidanol Drugs 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- -1 3,4-dihydroxyphenyl Chemical group 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 2
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000081822 Uncaria gambir Species 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000011167 hydrochloric acid Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 1
- DWJCNSIWWLBTEL-PZYMCFGQSA-N CN(C)C1([C@@H](CC(C[C@H]1O)(C=O)O)O)O Chemical compound CN(C)C1([C@@H](CC(C[C@H]1O)(C=O)O)O)O DWJCNSIWWLBTEL-PZYMCFGQSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000001159 Fisher's combined probability test Methods 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241000157352 Uncaria Species 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000024429 articular cartilage disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000015100 cartilage disease Diseases 0.000 description 1
- 201000005043 chondromalacia Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7107679 | 1979-08-30 | ||
| US06/071,076 US4285964A (en) | 1979-08-30 | 1979-08-30 | Salts of (+)-catechine, their preparation and use, and compositions containing these salts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI802652A7 FI802652A7 (fi) | 1981-03-01 |
| FI72724B FI72724B (fi) | 1987-03-31 |
| FI72724C true FI72724C (fi) | 1987-07-10 |
Family
ID=22099096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI802652A FI72724C (fi) | 1979-08-30 | 1980-08-22 | Foerfarande foer framstaellning av terapeutiskt aktiv, vattenloeslig associationsprodukt av (+)-katekin. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4285964A (enExample) |
| JP (2) | JPS5923313B2 (enExample) |
| AT (1) | AT372381B (enExample) |
| BE (1) | BE884743A (enExample) |
| CA (1) | CA1172259A (enExample) |
| CH (1) | CH646412A5 (enExample) |
| DE (1) | DE3031710C2 (enExample) |
| DK (1) | DK153948C (enExample) |
| ES (1) | ES8106513A1 (enExample) |
| FI (1) | FI72724C (enExample) |
| FR (1) | FR2464262A1 (enExample) |
| GB (1) | GB2057437B (enExample) |
| GR (1) | GR69849B (enExample) |
| IE (1) | IE50231B1 (enExample) |
| IT (1) | IT1193979B (enExample) |
| NL (1) | NL183080C (enExample) |
| NO (1) | NO156010C (enExample) |
| SE (1) | SE448455B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507314A (en) * | 1983-07-20 | 1985-03-26 | Midit, Societe Fiduciaire | Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections |
| EP0263132A4 (en) * | 1986-04-07 | 1988-11-16 | Clemetson Ab Charles | ASCORBIC ACID COATED WITH CATECHIN AND METHOD. |
| US4857320A (en) * | 1987-02-19 | 1989-08-15 | Monsanto Company | Method of enhancing the solubility of tissue plasminogen activator |
| JPH0662408B2 (ja) * | 1987-10-01 | 1994-08-17 | 太陽化学株式会社 | 抗う蝕及び抗歯周病組成物 |
| JPH0672091B2 (ja) * | 1988-04-13 | 1994-09-14 | 太陽化学株式会社 | 抗う蝕組成物 |
| US5090785A (en) * | 1990-07-31 | 1992-02-25 | Stamp John R | Multi-compartment container |
| CA2143515A1 (en) * | 1994-03-22 | 1995-09-23 | Prakash Parab | Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer |
| GB2306321A (en) * | 1995-10-24 | 1997-05-07 | Anne Child | The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders |
| GB9700912D0 (en) | 1997-01-17 | 1997-03-05 | Chiroscience Ltd | Resolution |
| US5804594A (en) * | 1997-01-22 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for improving wrinkles and other skin conditions |
| WO2001013865A1 (en) | 1999-08-20 | 2001-03-01 | Howard Murad | Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| US20030224071A1 (en) * | 1999-08-20 | 2003-12-04 | Howard Murad | Pharmaceutical compositions and methods for managing connective tissue ailments |
| US7252834B2 (en) | 2005-04-25 | 2007-08-07 | Clemson University Research Foundation (Curf) | Elastin stabilization of connective tissue |
| US20100069476A1 (en) * | 2005-05-17 | 2010-03-18 | Mitsui Norin Co., Ltd | Compositions and methods for reduction of cutaneous photoageing |
| WO2011014563A1 (en) | 2009-07-29 | 2011-02-03 | Vatrix Medical, Inc. | Tissue stabilization for heart failure |
| WO2011104667A1 (en) * | 2010-02-25 | 2011-09-01 | Anthem Biosciences Private Limited | Basic aminoacid salts of polyphenols |
| US8911468B2 (en) | 2011-01-31 | 2014-12-16 | Vatrix Medical, Inc. | Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection |
| JP2014516695A (ja) | 2011-05-18 | 2014-07-17 | バトリックス・メディカル・インコーポレイテッド | 血管安定化用被覆バルーン |
| BE1023772B9 (fr) | 2013-05-17 | 2017-08-02 | Valore | Composition a base d'un complexe de (+)-catechine et d'acide amine pour le traitement et la prevention du cancer |
| BE1022579A9 (fr) * | 2014-11-10 | 2016-10-06 | Valore | Composition antimétastatique comprenant au moins un composé de type flavanol |
| TWI761672B (zh) | 2018-04-23 | 2022-04-21 | 日商阿爾卑斯藥品工業股份有限公司 | O-醣苷基類黃酮之組成物 |
| US10617705B1 (en) | 2019-01-24 | 2020-04-14 | Alps Pharmaceutical Ind. Co., Ltd. | Isoquercitrin compositions |
| US10918654B1 (en) | 2019-09-23 | 2021-02-16 | Alps Pharmaceutical Ind. Co., Ltd. | Rutin compositions |
| US11110109B2 (en) | 2019-10-22 | 2021-09-07 | Alps Pharmaceutical Ind. Co., Ltd. | Water soluble O-glycosyl flavonoid compositions and methods for preparing same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270003A (en) * | 1964-08-07 | 1966-08-30 | Rayonier Inc | Iron complexed sulfonated polyflavonoids and their preparation |
| FR2128207B1 (enExample) * | 1971-03-11 | 1974-08-02 | Zyma Sa | |
| GB1575004A (en) * | 1976-03-23 | 1980-09-17 | Iverni Della Beffa Spa | Pharmacologically active polyphenolic substances |
| US4255336A (en) * | 1977-11-25 | 1981-03-10 | Ciba-Geigy Corporation | Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01 |
-
1979
- 1979-08-30 US US06/071,076 patent/US4285964A/en not_active Expired - Lifetime
-
1980
- 1980-08-12 BE BE0/201729A patent/BE884743A/fr not_active IP Right Cessation
- 1980-08-19 GB GB8026982A patent/GB2057437B/en not_active Expired
- 1980-08-20 GR GR62700A patent/GR69849B/el unknown
- 1980-08-21 DK DK358980A patent/DK153948C/da not_active IP Right Cessation
- 1980-08-22 DE DE3031710A patent/DE3031710C2/de not_active Expired
- 1980-08-22 SE SE8005890A patent/SE448455B/sv not_active IP Right Cessation
- 1980-08-22 FI FI802652A patent/FI72724C/fi not_active IP Right Cessation
- 1980-08-26 AT AT0432080A patent/AT372381B/de active
- 1980-08-27 IT IT24310/80A patent/IT1193979B/it active
- 1980-08-27 CH CH645780A patent/CH646412A5/fr not_active IP Right Cessation
- 1980-08-28 NL NLAANVRAGE8004873,A patent/NL183080C/xx not_active IP Right Cessation
- 1980-08-29 NO NO802563A patent/NO156010C/no unknown
- 1980-08-29 JP JP55119632A patent/JPS5923313B2/ja not_active Expired
- 1980-08-29 ES ES494668A patent/ES8106513A1/es not_active Expired
- 1980-08-29 IE IE1823/80A patent/IE50231B1/en unknown
- 1980-08-29 CA CA000359284A patent/CA1172259A/en not_active Expired
- 1980-08-29 FR FR8018813A patent/FR2464262A1/fr active Granted
-
1984
- 1984-01-20 JP JP59007386A patent/JPS5946947B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2057437A (en) | 1981-04-01 |
| NO802563L (no) | 1981-03-02 |
| GB2057437B (en) | 1984-08-30 |
| IT1193979B (it) | 1988-08-31 |
| JPS5923313B2 (ja) | 1984-06-01 |
| FR2464262B1 (enExample) | 1983-07-08 |
| ES494668A0 (es) | 1981-08-16 |
| FI72724B (fi) | 1987-03-31 |
| NL183080C (nl) | 1988-07-18 |
| CA1172259A (en) | 1984-08-07 |
| ES8106513A1 (es) | 1981-08-16 |
| JPS59144779A (ja) | 1984-08-18 |
| BE884743A (fr) | 1980-12-01 |
| FI802652A7 (fi) | 1981-03-01 |
| GR69849B (enExample) | 1982-07-19 |
| NO156010B (no) | 1987-03-30 |
| DK153948B (da) | 1988-09-26 |
| JPS5655386A (en) | 1981-05-15 |
| SE448455B (sv) | 1987-02-23 |
| ATA432080A (de) | 1983-02-15 |
| IE50231B1 (en) | 1986-03-05 |
| FR2464262A1 (fr) | 1981-03-06 |
| AT372381B (de) | 1983-09-26 |
| DE3031710C2 (de) | 1987-03-12 |
| CH646412A5 (fr) | 1984-11-30 |
| US4285964A (en) | 1981-08-25 |
| DE3031710A1 (de) | 1981-03-12 |
| IT8024310A0 (it) | 1980-08-27 |
| NL8004873A (nl) | 1981-03-03 |
| NO156010C (no) | 1987-07-08 |
| JPS5946947B2 (ja) | 1984-11-15 |
| IE801823L (en) | 1981-02-28 |
| DK358980A (da) | 1981-03-01 |
| DK153948C (da) | 1989-02-13 |
| SE8005890L (sv) | 1981-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI72724B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiv, vattenloeslig associationsprodukt av (+)-katekin. | |
| US4160827A (en) | Metronidazole phosphate and salts | |
| CN101707888B (zh) | 用7-乙基-10-羟基喜树碱的多臂聚合物缀合物治疗非霍奇金氏淋巴瘤 | |
| CA1261849A (en) | L-lysine pyruvate and l-histidine pyruvate | |
| JPH0244478B2 (enExample) | ||
| EP0142732A2 (en) | Pheophorbide derivatives and pharmaceutical preparations containing them | |
| HU184626B (en) | Congesting cosmetics first of all hair-restorers | |
| CA1242713A (en) | Process for preparation of a new hemin complex compound with medical applications | |
| PT93571B (pt) | Processo para a preparacao do acido (s)-7-(3-amino-1-pirrolidinil)-1-ciclopropil -6-fluoro-1,4-dihidro-4-oxo-1,8-naftiridino-3-carboxilico e de composicoes farmaceuticas que o contem | |
| JPS6041658A (ja) | 新規アミノ酸誘導体の製法 | |
| HU194877B (en) | Process for producing morpholinoethyl-ester-diniflumate of nifluminic acid and pharmaceutical composition containing them | |
| PL111745B1 (en) | Method of preparing of novel derivatives of amino acids | |
| EP0619817B1 (en) | Novel pharmaceutically active flavilium compounds | |
| EP3071238B1 (en) | Conjugate comprising indole-3-carbinol for medical use | |
| US4148912A (en) | Pharmaceutical compositions and methods of using the same | |
| US4314060A (en) | Oxaalkanoate anti-ulcer compounds | |
| US4263281A (en) | Oxaalkanoate anti-ulcer composition | |
| GB2072675A (en) | Cephapirin salts | |
| EP0022737B1 (fr) | Imines dérivées de l'amino-5 benzodioxole-1,3 utiles comme médicaments et leur préparation | |
| CN101781330A (zh) | 丙泊酚磷酸酯氨基酸复盐及其制备方法和应用 | |
| US4071517A (en) | Soluble salts containing sulphur | |
| US3663557A (en) | Biologically active forms of pyridoxine coenzymes | |
| JP3406334B2 (ja) | チロシン特異的リン酸化酵素阻害剤及び制癌剤 | |
| CN118108786A (zh) | 连接组织蛋白酶b裂解的10-氨基喜树碱类化合物及其合成方法和应用 | |
| CH665634A5 (en) | Stable soluble catechin complexes - with a double salt of L-lysine, for liver protection and digestive ulcers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: CONTINENTAL PHARMA INC. |